Citation Impact
Citing Papers
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
2017 Standout
Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors
2022
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
2017
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Understanding and targeting resistance mechanisms in NSCLC
2017
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Targeting apoptosis in cancer therapy
2020 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
<em>nab</em>-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors
2016
The molecular landscape of head and neck cancer
2018 Standout
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune System
2017
Leptomeningeal disease: current diagnostic and therapeutic strategies
2017
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Works of Satoru Kitazono being referenced
Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non–Small-Cell Lung Cancer
2015
EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer
2016
Efficacy of bevacizumab and erlotinib combination for leptomeningeal carcinomatosis after failure of erlotinib
2017
Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer
2015
Impact of Renin–angiotensin System Inhibitors on the Efficacy of Anti-PD-1/PD-L1 Antibodies in NSCLC Patients
2021